Showing results (2291-2300 of 5,261) with videos related to
Sort By:
Pageof 527
Oncology|January 19, 2023
Malignant Primary and Metastatic Cardiac Tumors: A Single-Center 27-Year Case ReviewPedro Garcia Brás, Luísa Moura Branco, Ana Galrinho, et al.Oncology|January 1, 1987
Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesisC F Pollera, E M Conti, A De Nigris, et al.Oncology|January 1, 1987
Antiemetic therapy in patients treated with high-dose cytosine arabinosideJ B Craig, B L Powell, D R White, et al.Oncology|June 28, 2022
Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal AdenocarcinomaXin Wang, Osvaldo Espin-Garcia, Di Maria Jiang, et al.Oncology|June 27, 2022
Growth Arrest-Specific 6 in Chromophobe Renal Cell CarcinomaMarie Mikuteit, Stefanie Zschäbitz, Maximilian Erlmeier, et al.Oncology|January 1, 1987
Potential antitumor agents: steroidal amidoesters with an alkylating moietyA Papageorgiou, L Boutis, S Nicolaropoulos, et al.Oncology|January 1, 1987
Chemotherapy of metastatic ameloblastoma. A case report and review of the literatureR J LanhamOncology|January 1, 1988
Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis?D Basso, C Fabris, G Del Favero, et al.Oncology|September 13, 2020
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)Thomas Steffen, Lukas Häller, Lana Bijelic, et al.Oncology|September 23, 2020
Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective StudyTakanori Miyoshi, Miyuki Uoi, Fuyuki Omura, et al.Pageof 527